CANF Can-Fite BioPharma Ltd.

AMEX
$3.33

Can-Fite BioPharma Ltd. (CANF) is expected to report earnings on March 26, 2026, before the market open.

Earnings Date
2nd Quarter, Jun 2026
Mar 26
Thursday · 7:00 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Can-Fite BioPharma Ltd.

Can Fite Biofarma Ltd is a clinical stage drug development company. The Company provides a platform of technology for the treatment of inflammatory diseases, sexual dysfunction, cancer and ophthalmic indications.

Sector

Healthcare

Industry

Biotechnology